Literature DB >> 5879892

[Medicinal treatment of urogenital tuberculosis with resistance against the "great remedies"].

F Balogh, D Frang, M Tóth, D Vecsey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5879892

Source DB:  PubMed          Journal:  Beitr Klin Erforsch Tuberk Lungenkr        ISSN: 0300-9696


× No keyword cloud information.
  15 in total

1.  [Secondary antitubercular agents].

Authors:  M BOSZORMENYI
Journal:  Orv Hetil       Date:  1963-07-07       Impact factor: 0.540

2.  [Experience with cycloserine therapy of urogenital tuberculosis].

Authors:  E BARANYAI; Z SZENDROI; A CSERNUS
Journal:  Orv Hetil       Date:  1961-01-15       Impact factor: 0.540

3.  [Tuberculostatics, combination and change of medication].

Authors:  E WILHELMI
Journal:  Urologe       Date:  1962-04-15       Impact factor: 0.639

4.  [Pyrazinamide in urology].

Authors:  L ZADOR; E BARANYAI; M OTH
Journal:  Magy Seb       Date:  1962-06

5.  [Clinical importance of mixed infection in renal tuberculosis].

Authors:  D VECSEY
Journal:  Tuberkulozis       Date:  1962-02

6.  [Our problems related to possibilities of modern therapy of renal tuberculosis].

Authors:  D VECSEY
Journal:  Orv Hetil       Date:  1961-01-15       Impact factor: 0.540

7.  [Advances in the therapy of urogenital tuberculosis].

Authors:  L ZADOR
Journal:  Tuberkulozis       Date:  1960-06

8.  The toxicology and pharmacology of primycin.

Authors:  T VALYI-NAGY; B KELENTEY
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-03-01

9.  [Bacteriological and clinical results with "resistomycin" (kanamycin "Bayer")].

Authors:  P HOFMANN; W BIECHTELER; F MEYTHALER; E HOFER; L RITTER; R BEDACHT
Journal:  Munch Med Wochenschr       Date:  1959-08-28

10.  Prognosis after nephrectomy for renal tuberculosis.

Authors:  G D OPPENHEIMER; L NARINS
Journal:  J Urol       Date:  1949-12       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.